Warfarin Toxicity: Causes and Management in Pasang Hospital, Lamphun Province, Thailand
Article Sidebar
Main Article Content
Abstract
This study aims to determine the causes and management of warfarin toxicity in outpatients who visited an anticoagulation clinic at Pasang Hospital, Lamphun, Thailand. This is a retrospective review of all outpatients who visited the anticoagulation clinic at Pasang Hospital between 1 January to 31 December 2018 with an international normalized ratio (INR) >3.0 and 3.5 in patients who have undergone mechanical mitral valve replacement. During the study period, 267 increased INR measurements (138 patients) met the inclusion criteria for warfarin toxicity. The prevalence of warfarin toxicity was 18.6% (267/1,434). The causes of warfarin toxicity were identified and addressed in 96.3% (257/267) of patients. Where the causes were identified, 57.1% (237/415) were due to drug-disease interaction and unstable underlying disease, and 36.6% (152/415) were due to drug-drug interaction. Major bleeding occurred in 3.7% (10/267) of patients. The management of patients who presented with warfarin toxicity depended on the degree of INR elevation and the severity of bleeding. Physicians’ adherence to the recommendations from published literatures was almost 100% (266/267) of patients. The INR value decreased in all patients (100%, 267/267) after the intervention given. In conclusion, warfarin toxicity is quite common and is best managed by a multidisciplinary team in order to prevent warfarin toxicity effectively.
Article Details
References
Jacobs A, Bassa F, Decloedt EH. A preliminary review of warfarin toxicity in a tertiary hospital in Cape Town, South Africa. Cardiovasc J Afr 2017; 28(6): 346-9.
Tajai P, Warinruk J, Sunkwan T. The effects of pharmacist's counseling on warfarin-related clinical outcomes in pharmacy's ambulatory care. Bull Health Sci Technol 2018; 16(2): 102-8. ISSN 0858-7531.
Ababneh MA, Al-Azzam SI, Alzoubi KH, et al. Adherence in outpatients taking warfarin and its effect on anticoagulation control in Jordan. Int J Clin Pharm 2016; 38(4): 816-21.
Abdel-Aziz MI, Ali MA, Hassan AK, et al. Factors influencing warfarin response in hospitalized patients. Saudi Pharm J 2015; 23(6): 642-9.
Shrestha S, Sapkota B, Kumpakha A, et al. Evaluation of patients' knowledge on warfarin in outpatient pharmacy of a tertiary care cardiac center. BMC Res Notes 2015; 8: 429.
Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. Bmj 2002; 325(7372): 1073-5.
Menzin J, Hoesche J, Friedman M, et al. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. J Thromb Haemost 2012; 10(4): 596-605.
Oden A, Fahlen M, Hart RG. Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Thromb Res 2006; 117(5): 493-9.
Westaway K, Cruickshank M, Roberts GW, et al. Factors influencing over-anticoagulation and bleeding in warfarin therapy during the initial five months of treatment. Aust Nurs J 2010; 17(10): 28-31.
Thongarporn S. Prevalence of adverse drug reactions and factors affecting bleeding from warfarin usage in Southern Thai patients, 2012.
Available at http://kb.psu.ac.th/psukb/ handle/2010/8979, accessed Jan 1, 2020.
Gage BF, Fihn SD, White RH. Management and dosing of warfarin therapy. Am J Med 2000; 109(6): 481-8.
Self TH, Owens RE, Sakaan SA, et al. Effect of diseases on response to vitamin K antagonists. Curr Med Res Opin 2016; 32(4): 613-20.
Tran HA, Chunilal SD, Harper PL, et al. An update of consensus guidelines for warfarin reversal. Med J Aust 2013; 198(4): 198-9.
Wigle P, Hein B, Bloomfield HE, et al. Updated guidelines on outpatient anticoagulation. Am Fam Physician 2013; 87(8): 556-66.
Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based clinical practice guidelines. Chest 2012 Feb; 141(2 Suppl): e152S-e184S. doi: 10.1378/chest.11-2295.
Deaton JG, Nappe TM. Warfarin Toxicity, 2019. Available at https://www.ncbi.nlm.nih.gov/books/NBK431112/, accessed Jan 1, 2020.
Tuntisirisomboon P. Causes affecting supratherapeutic INR of warfarin therapy, its adverse events and management in Sawanpracharak hospital. Sawanpracharak Med J 2010; 7(1): 45-59.
Lind M, Fahlen M, Kosiborod M, et al. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation. Thromb Res 2012; 129(1): 32-5.
Cruickshank J, Ragg M, Eddey D. Warfarin toxicity in the emergency department: recommendations for management. Emerg Med (Fremantle) 2001; 13(1): 91-7.
Atreja A, El-Sameed YA, Jneid H, et al. Elevated international normalized ratio in the ED: clinical course and physician adherence to the published recommendations. Am J Emerg Med 2005; 23(1): 40-4.
Jarernsiripornkul N, Polkote N. Retrospective study of adverse drug reactions from warfarin at Srinagarind hospital, Khon Kaen province. KKU Res J 2006; 11(3): 228-36.
Tantiviyavanit J, Chaiyasu R. Effects of pharmaceutical care on patients taking warfarin at Pattani hospital. Thai Journal of Pharmacy Practice 2013; 5(2): 108-19.
Lertsinudom S, Chumworathayi P, Chaiyakum A. Drug use review of warfarin in medicine ward, Srinagarind hospital. Srinagarind Med J 2010; 25(1): 6-13.
